# Korean Multicenter Randomized Controlled Trial (RCT) of Pidogul for Patients With Coronary Stenting

> **NCT01584791** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 148 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** clopidogrel napadisilate + aspirin
- **DRUG:** clopidogrel bisulfate + aspirin

## Key facts

- **NCT ID:** NCT01584791
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2012-02
- **Final completion:** —
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2012-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01584791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01584791, "Korean Multicenter Randomized Controlled Trial (RCT) of Pidogul for Patients With Coronary Stenting". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01584791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*